Fidelity Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7
Closed -$165 5295
2024
Q4
$165 Buy
7
+5
+250% +$123 ﹤0.01% 5065
2024
Q3
$51 Buy
2
+1
+100% +$25 ﹤0.01% 5173
2024
Q2
$23 Sell
1
-512
-100% -$12.9K ﹤0.01% 5168
2024
Q1
$14.8K Buy
513
+319
+164% +$9.59K ﹤0.01% 4141
2023
Q4
$6.37K Buy
194
+191
+6,367% +$5.19K ﹤0.01% 4375
2023
Q3
$84 Sell
3
-3
-50% -$98 ﹤0.01% 4874
2023
Q2
$205 Buy
6
+3
+100% +$94 ﹤0.01% 4900
2023
Q1
$90 Sell
3
-5
-63% -$155 ﹤0.01% 4914
2022
Q4
$226 Buy
8
+4
+100% +$127 ﹤0.01% 4811
2022
Q3
$0 Buy
4
+1
+33% +$37 ﹤0.01% 4819
2022
Q2
$0 Sell
3
-12
-80% -$420 ﹤0.01% 4884
2022
Q1
$0 Sell
15
-3
-17% -$143 ﹤0.01% 4927
2021
Q4
$1K Buy
18
+10
+125% +$691 ﹤0.01% 4090
2021
Q3
$1K Sell
8
-215
-96% -$18K ﹤0.01% 4088
2021
Q2
$20K Buy
223
+138
+162% +$11.7K ﹤0.01% 3375
2021
Q1
$7K Buy
+85
New +$8.43K ﹤0.01% 3461
2020
Q2
Sell
-1
Closed 3560
2020
Q1
$0 Buy
+1
New +$33 ﹤0.01% 3598
2019
Q3
Sell
-2
Closed 3754
2019
Q2
$0 Buy
+2
New +$64 ﹤0.01% 3719

Other funds holding ARKG

Fidelity Investments's ARKG Position: Q1 2025 in Review

Fidelity Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 7 shares — an estimated $165 sold.

Fidelity Investments first reported a position in ARKG in Q2 2019 and held it in 18 quarters. The position peaked at $20K in Q2 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Fidelity Investments reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 7 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $165.
  • Fidelity Investments first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 18 quarters.
  • Fidelity Investments's ARK Genomic Revolution ETF position peaked at $20K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.